Our Clients
We provide biopharmaceutical, medical device companies and research institutions with expertise tailored to your goals. Specifically, we assist in securing:- Out-licenses
- New products for in-licensing
- R&D collaborations
- Mergers & acquisitions
- Quid products and divestitures
What We Do
Our core expertise and capabilities achieve positive results through:- Rapid establishment of a commercial and transactional strategy to support assets and your business development needs
- Utilization of our extensive knowledge of product opportunities and network of business development and disease franchise teams to accelerate the process of securing products and partners
- Top-level guidance and enablement of asset presentation to partners, deal construction, contract negotiation and execution of high value transactions
Our Process
Step One - Evaluate or confirm the commercial strategy of your in-licensing goals or your product opportunities.Step Two - Once we have a partnering mandate from you, we provide strategic advice and assistance on product positioning, create business development materials and access our extensive contact base for meetings. If your primary goal is to in-license, we can help delve into the "white spaces," such as new disease areas, new or niche geographic markets and innovative mechanisms of action, and uncover hidden product opportunities. For out-licensing, we utilize our network of contacts, and knowledge of pharma, mid-cap and specialty company portfolio priorities for partner out-reach and deal activation.
Expertise
- Biologics, pharmaceuticals and enabling technologies in diverse therapeutic areas including CNS, cardiovascular disease, oncology, immunology, and underexploited disease areas
- Medical device technologies including diagnostics and diagnostic/therapeutic combination products
